Search
The WasteWatcherSenators Need to Check Their Conscience Before Voting for Price Controls
Senators must understand that price controls will harm patients and reduce the development of future cures.
The WasteWatcherStimulus Checks Will Make Inflation Worse, Not Better
Pumping more money into the economy will add to inflation and do more harm in the long term.
The WasteWatcherThe Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.
The WasteWatcherPrice Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The WasteWatcherThe Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
The WasteWatcherLimiting Access to Tobacco Harm Reduction Products Harms Public Health
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
The WasteWatcherRegulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
The WasteWatcherVaping Saves Lives
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.
The WasteWatcherSen. Elizabeth Warren Wants the Government to Steal IP and Stifle Future Pharmaceutical Innovation
Sen. Elizabeth Warren (D-Mass.) urges HHS to steal and redistribute intellectual property as a mechanism to lower drug prices.
The WasteWatcherIntellectual Property Rights Must Be Protected So the Next Vaccines Can Be Developed
Intellectual property must be protected to encourage the development of future cures.
The WasteWatcherVirginia Passes Legislation to Extend Cocktails To-Go Until 2024
Cocktails to-go have helped many business stay afloat during the pandemic and Virginia has extended this policy.
The WasteWatcherPresident Biden Again Tries to Undermine U.S. Biomedical Innovation
President Biden’s support of intellectual property waivers threatens development of future life-saving medicines.
